Target Employers Focus sales on mid-size U.S. employers with musculoskeletal risk. The EFA-STM program delivers ADA and EEOC compliant baseline and post-injury assessments with objective diagnoses, giving HR and safety teams a defensible way to improve outcomes and reduce workers’ comp costs.

Telemedicine Advantage Leverage remote diagnostic and IME capabilities to pitch cost-efficient, fast assessments for distributed and hybrid workforces. The telemedicine enabled EFA platform can streamline claims handling for insurers, TPAs, and employers.

Partnership Opportunities Position as a complementary service for workers' compensation and disability claims by partnering with insurers and third party administrators. Past collaborations, such as with Genex, illustrate pathways to integrated IME-EFA programs that reduce claims costs and improve outcomes.

Unique Differentiator FDA registered class II device with objective muscle activity data and baseline versus post injury comparison stored securely. This differentiates from traditional IMEs and supports data driven decisions.

Growth Platform Cross-sell with the Emerge Diagnostics Wellness Platform and remote employee health services to employers prioritizing musculoskeletal wellness. The 2022 platform launches show readiness to expand into preventive health and telemedicine services.